Skip to main content

Want a detailed portfolio tracker?

Geron (GERN) P/E (2006 - 2026)

Geron (GERN) P/E from Mar 31, 2006 to Jul 21, 2026. The TTM Geron (GERN) P/E is -13.80. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Geron (GERN)

YearP/EChange
2026-13.80+34.55%
2025-10.26-20.58%
2024-12.92+109.23%
2023-6.17-8.57%
2022-6.75+96.14%
2021-3.44-38.94%
2020-5.64+48.04%
2019-3.81-41.32%
2018-6.49-34.39%
2017-9.89-11.13%
2016-11.13-98.93%
2015-1.04K+7358.93%
2014-13.99-11.64%
2013-15.83+509.27%
2012-2.60+98.79%
2011-1.31-71.07%
2010-4.52-34.98%
2009-6.95+18.06%
2008-5.88-49.30%
2007-11.61-43.47%
2006-20.53N/A

Comparison Geron (GERN) P/E with competitors

Geron (GERN) P/E is -13.80.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.03%
ENLVEnlivex Ltd0.07-100.54%
FGENFibroGen Inc0.24-101.74%
CHRSCoherus Biosciences Inc0.85-106.15%
FBIOFortress Biotech Inc0.95-106.87%
ORMPOramed Pharmaceuticals Inc1.50-110.89%
AGENAgenus Inc3.01-121.80%
INVAInnoviva Inc3.15-122.85%
VXRTVaxart Inc3.55-125.71%
CRMDCorMedix Inc3.63-126.28%
CVACCureVac N.V.4.45-132.20%
GLPGGalapagos NV4.86-135.20%
SRPTSarepta Therapeutics Inc4.88-135.36%
ABEOAbeona Therapeutics Inc5.39-139.03%
ABUSArbutus Biopharma Corp5.60-140.53%
ZVRAZevra Therapeutics Inc5.89-142.65%
SPROSpero Therapeutics Inc6.23-145.12%
CGENCompugen Ltd6.31-145.74%
RIGLRigel Pharmaceuticals6.87-149.78%
SLXNSilexion Therapeutics Corp7.30-152.85%
OMEROmeros Corporation9.26-167.07%
AUPHAurinia Pharmaceuticals Inc9.58-169.43%
PLXProtalix BioTherapeutics Inc10.89-178.89%
ACADAcadia Pharmaceuticals Inc11.73-184.96%
TBPHTheravance Biopharma Inc12.26-188.82%
ADMAAdma Biologics Inc12.42-189.95%
HRMYHarmony Biosciences Holdings Inc13.82-200.11%
SABSSAB Biotherapeutics Inc14.14-202.40%
NAGENiagen Bioscience Inc14.82-207.34%
INCYIncyte Corp15.82-214.61%
REGNRegeneron Pharmaceuticals Inc15.86-214.86%
PBYIPuma Biotechnology Inc17.32-225.43%
CPRXCatalyst Pharmaceuticals Inc17.44-226.33%
EXELExelixis Inc17.54-227.04%
TGTXTG Therapeutics Inc18.97-237.38%
MDXGMimedx Group Inc20.55-248.88%
XOMAXOMA Royalty Corp22.87-265.70%
ARGXArgen X SE24.30-276.01%
CTMXCytomX Therapeutics Inc24.82-279.80%
XOMAOXOMA Royalty Corp25.34-283.60%
HALOHalozyme Therapeutics Inc25.62-285.62%
XOMAPXOMA Royalty Corp25.67-285.95%
VRTXVertex Pharmaceuticals Inc27.99-302.79%
RPRXRoyalty Pharma plc - Class A28.69-307.81%
SLNOSoleno Therapeutics Inc29.02-310.18%
ASNDAscendis Pharma A/S30.09-317.94%
LGNDLigand Pharmaceuticals Inc - Class B37.91-374.63%
APLSApellis Pharmaceuticals Inc39.02-382.67%
BMRNBiomarin Pharmaceutical Inc42.21-405.78%
KRYSKrystal Biotech Inc45.34-428.46%
ONCBeiGene Ltd69.54-603.75%
PHARPharming Group N.V.75.03-643.48%
TECHBio-Techne Corp101.96-838.58%
VCELVericel Corp109.92-896.26%
ALNYAlnylam Pharmaceuticals Inc117.96-954.53%
GMABGenmab140.29-1116.26%
TLXTelix Pharmaceuticals Ltd162.15-1274.62%
CORTCorcept Therapeutics Inc212.86-1641.92%